158 related articles for article (PubMed ID: 1664769)
1. Effect of dexamethasone implanted in different brain areas on the morphine-induced PRL, GH and ACTH/corticosterone secretion.
Kiem DT; Bartha L; Makara GB
Brain Res; 1991 Nov; 563(1-2):107-13. PubMed ID: 1664769
[TBL] [Abstract][Full Text] [Related]
2. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion.
Kovács KJ; Makara GB
Brain Res; 1988 Dec; 474(2):205-10. PubMed ID: 2850089
[TBL] [Abstract][Full Text] [Related]
3. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinizing hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways.
Smallridge RC; Carr FE; Fein HG
Toxicol Appl Pharmacol; 1991 Apr; 108(2):284-95. PubMed ID: 1673267
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids.
Señarís RM; Lago F; Coya R; Pineda J; Diéguez C
Endocrinology; 1996 Dec; 137(12):5236-41. PubMed ID: 8940340
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
Calogero AE; Liapi C; Chrousos GP
J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
Bromek E; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
[TBL] [Abstract][Full Text] [Related]
7. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the central effect of dexamethasone at the hypothalamic level in the negative feedback mechanism.
Feldman S; Weidenfeld J
Brain Res; 2002 Dec; 958(2):291-6. PubMed ID: 12470864
[TBL] [Abstract][Full Text] [Related]
9. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli.
Feldman S; Saphier D; Weidenfeld J
Brain Res; 1992 Apr; 578(1-2):251-5. PubMed ID: 1324761
[TBL] [Abstract][Full Text] [Related]
10. ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats.
Jezová D; Vigas M; Jurcovicová J
Life Sci; 1982 Jul; 31(4):307-14. PubMed ID: 6292645
[TBL] [Abstract][Full Text] [Related]
11. Lesioning of the hypothalamic paraventricular nucleus inhibits ether-induced ACTH but not prolactin release.
Makara GB; Kovács KJ
Neurobiology (Bp); 1997; 5(3):403-11. PubMed ID: 9503384
[TBL] [Abstract][Full Text] [Related]
12. The reverse role of the hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in the central serotonergic regulation of the liver cytochrome P450 isoform CYP2C11.
Rysz M; Bromek E; Haduch A; Liskova B; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2016 Jul; 112():82-9. PubMed ID: 27137992
[TBL] [Abstract][Full Text] [Related]
13. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat.
Minamitani N; Minamitani T; Lechan RM; Bollinger-Gruber J; Reichlin S
Endocrinology; 1987 Mar; 120(3):860-7. PubMed ID: 3542515
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of suckling-induced prolactin release by dexamethasone.
Bartha L; Nagy GM; Kiem DT; Fekete MI; Makara GB
Endocrinology; 1991 Aug; 129(2):635-40. PubMed ID: 1855462
[TBL] [Abstract][Full Text] [Related]
15. Neonatal treatment with monosodium-L-glutamate: differential effects on growth hormone and prolactin release induced by morphine.
Antoni FA; Kanyicska B; Mezey E; Makara GB
Neuroendocrinology; 1982 Oct; 35(4):231-5. PubMed ID: 7145019
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of growth hormone and prolactin release from rat pituitary cell aggregates by bombesin- and ranatensin-like peptides is potentiated by estradiol, 5 alpha-dihydrotestosterone, and dexamethasone.
Houben H; Denef C
Endocrinology; 1990 May; 126(5):2257-66. PubMed ID: 2328688
[TBL] [Abstract][Full Text] [Related]
17. Differential sites of action of 8OHDPAT, a 5HT1A agonist, on ACTH and PRL secretion in the rat.
Bluet Pajot MT; Mounier F; di Sciullo A; Schmidt B; Kordon C
Neuroendocrinology; 1995 Feb; 61(2):159-66. PubMed ID: 7753334
[TBL] [Abstract][Full Text] [Related]
18. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L
Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900
[TBL] [Abstract][Full Text] [Related]
19. Adenohypophyseal hormone response to chronic stress in dexamethasone-treated rats.
Taché Y; Du Ruisseau P; Ducharme JR; Collu R
Horm Res; 1979; 11(2):101-8. PubMed ID: 478439
[TBL] [Abstract][Full Text] [Related]
20. Infusion of alpha-2-adrenergic agents into the paraventricular and arcuate nuclei of the hypothalamus in the Siberian hamster: opposing effects on basal prolactin.
Dodge JC; Badura LL
Neuroendocrinology; 2002 Mar; 75(3):175-84. PubMed ID: 11914589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
